Emerging research suggests a complex interaction between the gut microbiome and endometriosis. Recent studies have begun to explore the impact of dietary interventions on endometriosis.
Clinical translation of microbiome research: takeaways from the 2025 GMFH Summit
16 May 2025by Andreu Prados
The 13th Gut Microbiota for Health World Summit took place 15-16 March 2025 in Washington, D.C., and it focused on advances in microbiome research to diagnose, prevent, and manage gastrointestinal and extra-intestinal conditions. Find out more about the most valuable takeaways from the event.
Carbohydrate malabsorption is an underlying cause of irritable bowel syndrome-type symptoms in some patients. This article explores the impact of fermentable short-chain carbohydrates (FODMAPs) on gut function, the benefits and risks of a low-FODMAP diet, and how probiotics can help individuals with carbohydrate malabsorption.
The fourth edition of IBS Days covered the latest IBS diagnosis and treatment advances in a postgraduate course. Read about the highlights and discussions (part 2).
IBS Days 2024: what’s new in the pathophysiology of IBS, overlapping conditions, and non-prescription microbiome-based therapeutics?
12 Aug 2024by Andreu Prados
June 17-19 2024, Gut Microbiota for Health attended the fourth edition of IBS Days 2024 in Bologna, Italy, alongside 400 in-person attendees. Find out more about the most relevant basic, translational, and clinical science highlights in IBS (part 1).
Unlocking the diagnostic and therapeutic potential roles of gut microbiome: takeaways from the 2024 GMFH Summit
23 May 2024by Joël Doré, Andreu Prados
The last 12th Gut Microbiota for Health World Summit took place 23-24 March 2024 in Washington, D.C. and focused on relevant gut microbiome advances from the lab to the clinic. Find out more about the main takeaways of the conference and how they might affect your research and practice.
Why addressing how our brain and our gut talk to each other matter for IBS
19 Feb 2024by Premysl Bercik, Andreu Prados
While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.
Alterations in the gut microbiome composition and functions are emerging as a potential target for managing IBS. Discover how microbiota-modifying treatments, including prebiotics, probiotics, antibiotics, and fecal microbiota transplantation, hold promise in alleviating symptoms of this vexing condition.
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
4 Dec 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
Research highlights from NeuroGASTRO 2023: food, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction
6 Nov 2023by Andreu Prados, Rene van den Wijngaard
NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of the gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more what the latest research says about the involvement of the intestinal microbiota, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction and dietary considerations in their management picked up by GMFH editors (Part 1).
